GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seagen Inc (MEX:SGEN) » Definitions » Total Current Liabilities

Seagen (MEX:SGEN) Total Current Liabilities : MXN16,630 Mil (As of Sep. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Seagen Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Seagen's total current liabilities for the quarter that ended in Sep. 2023 was MXN16,630

Seagen Total Current Liabilities Historical Data

The historical data trend for Seagen's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Seagen Total Current Liabilities Chart

Seagen Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,419.29 4,891.47 7,720.84 11,669.47 15,955.60

Seagen Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,603.45 15,955.60 12,855.94 13,079.05 16,630.10

Seagen Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Seagen's Total Current Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=12533.939+0
+Other Current Liabilities+Current Deferred Liabilities
=3421.665+0
=15,956

Seagen's Total Current Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=12929.594+0
+Other Current Liabilities+Current Deferred Liabilities
=3700.506+0
=16,630

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Seagen Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Seagen's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Seagen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Seagen Inc (MEX:SGEN) » Definitions » Total Current Liabilities
Comparable Companies
MRNA BNTX ALNY BGNE BMRN INCY RPRX TECH KRTX LEGN OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 XKRX:068270 XBRU:ARGX OCSE:GMAB SZSE:300122 XBRU:UCB
Traded in Other Exchanges
N/A
Address
21823 - 30th Drive South East, Bothell, WA, USA, 98021
Website
https://www.seagen.com
Seagen (formerly known as Seattle Genetics) is a biotech firm that develops and commercializes therapies to treat cancers. Seagen's therapies are based on antibody-drug conjugate technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. The company's lead product, Adcetris, has received approval for six indications to treat Hodgkin lymphoma and T-cell lymphoma. Other approved products include Padcev for bladder cancer, Tukysa for breast cancer, and Tivdak for cervical cancer. The company has several other oncology programs in pivotal trials. Seagen also licenses its antibody-drug conjugate technology to several leading biotechnology and pharmaceutical companies.